Lyra Therapeutics, Inc. Proclaims Goal to Voluntarily Record Shape 25 for Delisting from Nasdaq and Next Deregistration with the SEC
WATERTOWN, Mass., April 17, 2026 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (the…
WATERTOWN, Mass., April 17, 2026 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (the…

Sign in to your account
